OptimizeRx Corp. (OTCMKTS:OPRX) was upgraded by equities researchers at ValuEngine from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Friday.

Shares of OptimizeRx Corp. (OPRX) traded down 0.0079% on Friday, hitting $1.2699. The stock had a trading volume of 2,805 shares. OptimizeRx Corp. has a one year low of $0.63 and a one year high of $1.30. The firm’s 50 day moving average is $1.17 and its 200-day moving average is $0.89. The stock’s market capitalization is $37.15 million.

OptimizeRx Corp. (OTCMKTS:OPRX) last released its earnings results on Tuesday, August 1st. The technology company reported ($0.01) earnings per share (EPS) for the quarter. OptimizeRx Corp. had a negative return on equity of 25.08% and a negative net margin of 20.24%. The company had revenue of $2.87 million for the quarter. Equities research analysts expect that OptimizeRx Corp. will post ($0.06) earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “OptimizeRx Corp. (OPRX) Stock Rating Upgraded by ValuEngine” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright legislation. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/09/01/optimizerx-corp-oprx-stock-rating-upgraded-by-valuengine.html.

About OptimizeRx Corp.

OptimizeRx Corporation is a technology solutions company. The Company focuses on the healthcare industry. The Company connects patients, physicians and pharmaceutical manufacturers through technology. The Company’s solutions provide pharmaceutical manufacturers a direct to physician channel for communicating and promoting products.

Receive News & Stock Ratings for OptimizeRx Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx Corp. and related stocks with our FREE daily email newsletter.